MEDICAL ONCOLOGY BEST PRACTICES – ON DEMAND 2020

Categories: All Products, Hematology Courses, Obstetrics / Gynecology Courses, Oncology Courses

Description
Additional information

GW’s MEDICAL ONCOLOGY BEST PRACTICES – ON DEMAND 2020

46 Videos , Course Size = 28.81 GB

YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT

GW’s Oncology Best Practices on Demand is the most comprehensive board review for physicians preparing to take the Hematology certification exams or those desiring a comprehensive update of medical oncology standards of care.

This course features Up to 44.50 hours of comprehensive, exam-focused content, patterned after the medical oncology ABIM Blueprint.

COURSE HIGHLIGHTS

1-year access to high quality video presentations featuring the nation’s leading clinician-educators (streaming media and downloadable audio)
All content can be conveniently accessed from any computer, mobile device, or smartphone
Practice exam with questions
Access to the course electronic syllabus
CME credits and MOC points

TARGET AUDIENCE

This course is ideal for physicians preparing to take the Medical Oncology certification exams as well as individuals desiring a comprehensive review of medical oncology standards of care.

LEARNING OBJECTIVES

At the conclusion of the Medical Oncology Best Practices course, the successful learner will be able to:

Hematologic Malignancies

be familiar with the diagnosis, evaluation, and management of hematologic malignancies;
understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs; and
identify strategies for taking the board examinations.

Oncology

understand the epidemiology of malignant diseases and management of the medical complications of malignancy;
recognize the latest advances in cancers of the lung, the breast, and the gastrointestinal tract;
understand the principles of management of gynecologic and other genito-urinary malignancies;
contend with complexity of HIV related malignancies;
recognize principles of new developments in biologic therapy of cancer.